Increased OIT3 in macrophages promotes PD-L1 expression and hepatocellular carcinogenesis via NF-κB signaling

Exp Cell Res. 2023 Jul 15;428(2):113651. doi: 10.1016/j.yexcr.2023.113651. Epub 2023 May 16.

Abstract

Oncoprotein-induced transcript 3 (OIT3) facilitates macrophage M2 polarization and hepatocellular carcinoma (HCC) progression, however, whether OIT3 regulates tumor immunity remains largely unknown. Here we found that OIT3 was upregulated in HCC-associated macrophages, which inhibited CD4+ and CD8+ T-cell infiltration in the tumor microenvironment (TME). Mechanistically, OIT3 increased the expression of PD-L1 on tumor-associated macrophages (TAMs) by activating NF-κB signaling, blockade of NF-κB reversed the immunosuppressive activity of TAMs and dampens HCC tumorigenesis. Our findings provide the molecular basis for OIT3 enhancing tumor immunosuppression and highlighted a potential therapeutic strategy for targeting the TAMs of HCC.

Keywords: NF-κB signaling; Oncoprotein-induced transcript 3; PD-L1; Tumor associated macrophages; Tumor microenvironment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B7-H1 Antigen / metabolism
  • Carcinogenesis / pathology
  • Carcinoma, Hepatocellular* / metabolism
  • Cell Line, Tumor
  • Humans
  • Liver Neoplasms* / metabolism
  • Macrophages / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Oncogene Proteins / metabolism
  • Tumor Microenvironment

Substances

  • B7-H1 Antigen
  • NF-kappa B
  • Oncogene Proteins
  • OIT3 protein, human